Moclobemide and selegeline in the treatment of depression in Parkinson's disease.
Steur
E N
EN
Ballering
L A
LA
D000928:Antidepressive Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000150:complications*; D012642:Selegiline / Q000627:therapeutic use*
D000928:Antidepressive Agents; D001549:Benzamides; D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline; D020912:Moclobemide